Humana Inc (HUM)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 1,207,000 1,359,000 1,711,000 1,991,000 2,489,000 3,015,000 3,376,000 3,114,000 2,805,000 2,806,000 3,144,000 3,035,000 2,933,000 2,673,000 2,482,000 3,722,000 3,367,000 4,153,000 3,502,000 2,614,000
Total stockholders’ equity US$ in thousands 16,375,000 17,565,000 16,671,000 16,130,000 16,262,000 16,949,000 16,834,000 16,577,000 15,311,000 16,254,000 15,490,000 15,319,000 16,080,000 16,260,000 14,843,000 14,190,000 13,728,000 15,768,000 14,416,000 12,355,000
ROE 7.37% 7.74% 10.26% 12.34% 15.31% 17.79% 20.05% 18.79% 18.32% 17.26% 20.30% 19.81% 18.24% 16.44% 16.72% 26.23% 24.53% 26.34% 24.29% 21.16%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $1,207,000K ÷ $16,375,000K
= 7.37%

Humana Inc's return on equity (ROE) shows fluctuations over the years, ranging from a high of 26.34% in September 2020 to a low of 7.37% in December 2024. The ROE generally remained above 15%, indicating that the company was efficiently utilizing shareholder equity to generate profits during this period. However, there was a noticeable downward trend in ROE from mid-2022 onwards, suggesting potential challenges in maintaining profitability and efficiency in utilizing equity. It is essential for investors and stakeholders to monitor this trend closely to assess the company's financial performance and sustainability in the long run.


See also:

Humana Inc Return on Equity (ROE) (Quarterly Data)